(3R)-3-tert-butylcyclopentan-1-one
Structure Info
- Chemspace ID
- CSSB00010633516 (In-Stock Building Blocks)
- MFCD
- MFCD24688721, MFCD24688903
- IUPAC Name
- (3R)-3-tert-butylcyclopentan-1-one
- Mol formula
- C9H16O
- Mol weight
- 140 Da
- Catalog Number(s)
- 10R0995, 10R0996, ArZ-UP376894, ArZ-UP504491, BBV-45455464, CSC010633516, FCH2008188, IMED1513678961, Y1127030, ZXC150030, ZXC220124
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.36
- Heavy atoms count
- 10
- Rotatable bond count
- 1
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.888
- Polar surface area (Å)
- 17
- Hydrogen bond acceptors count
- 1
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSB00010633516
Items Overall 3 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 500 mg | 2,197.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 1 g | 3,168.00 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 5 g | 10,868.00 | |
Description: (R)-3-tert-Butyl-cyclopentanone; CAS: 6672-31-7 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of (1S,2R,3S,5R,6S,8R,9S,10S,13S,16S,17R,18S)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one - CSSB06744482263](/st/structure/200/e19ee15db340bd83fd34a3350ebb3f05/CCN1C%255BC%2540%255D2%2528COC%2529CC%255BC%2540H%255D%2528O%2529%255BC%2540%2540%255D34%255BC%2540%2540H%255D5C%255BC%2540%2540H%255D6%255BC%2540H%255D%2528C%255BC%2540%2540%255D%2528O%2529%2528%255BC%2540H%255D5C6%253DO%2529%255BC%2540%2540%255D%2528O%2529%2528%255BC%2540%2540H%255D%2528OC%2529%255BC%2540H%255D23%2529%255BC%2540%2540H%255D14%2529OC.png)
![Chemical structure of (1S,2R,3S,5R,6S,8R,9S,10S,13S,16S,17R,18S)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one - CSSB06744482262](/st/structure/200/4b6dcafa67ceda408506b491e0d4fa19/CCN1C%255BC%2540%255D2%2528COC%2529CC%255BC%2540H%255D%2528OC%2529%255BC%2540%2540%255D34%255BC%2540%2540H%255D5C%255BC%2540%2540H%255D6%255BC%2540H%255D%2528C%255BC%2540%2540%255D%2528O%2529%2528%255BC%2540H%255D5C6%253DO%2529%255BC%2540%2540%255D%2528O%2529%2528%255BC%2540%2540H%255D%2528OC%2529%255BC%2540H%255D23%2529%255BC%2540%2540H%255D14%2529OC.png)
![Chemical structure of (1S,2R,3S,5R,6S,8R,9S,13S,16S,17R,18S)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one - CSSB20572401104](/st/structure/200/d830d65fe183a65dd7eee303e7d69f97/CCN1C%255BC%2540%255D2%2528COC%2529CC%255BC%2540H%255D%2528OC%2529%255BC%2540%2540%255D34%255BC%2540%2540H%255D5C%255BC%2540%2540H%255D6%255BC%2540H%255D%2528C%255BC%2540%2540%255D%2528O%2529%2528%255BC%2540H%255D5C6%253DO%2529%255BC%2540%2540%255D%2528O%2529%2528%255BC%2540%2540H%255D%2528OC%2529%255BC%2540H%255D23%2529C14%2529OC.png)







